Centessa Pharmaceuticals PLC (CNTA)
16.02
+0.12
(+0.75%)
USD |
NASDAQ |
Nov 05, 11:33
Centessa Pharmaceuticals Shareholders Equity (Quarterly): 286.96M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 286.96M |
| March 31, 2024 | 215.16M |
| December 31, 2023 | 236.24M |
| September 30, 2023 | 259.39M |
| June 30, 2023 | 276.61M |
| March 31, 2023 | 293.26M |
| December 31, 2022 | 336.17M |
| Date | Value |
|---|---|
| September 30, 2022 | 372.92M |
| June 30, 2022 | 420.04M |
| March 31, 2022 | 480.15M |
| December 31, 2021 | 491.55M |
| September 30, 2021 | 549.13M |
| June 30, 2021 | 585.64M |
| March 31, 2021 | 278.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
215.16M
Minimum
Mar 2024
585.64M
Maximum
Jun 2021
362.99M
Average
314.72M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 168.27M |
| Autolus Therapeutics PLC | 527.84M |
| Mereo BioPharma Group PLC | 78.65M |
| Achilles Therapeutics PLC | 115.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 398.84M |
| Total Liabilities (Quarterly) | 111.88M |